₩79,200.00
1.28%
Korea, Sep 17, 03:30 pm KST. Closed.
ISIN
KR7326030004
Symbol
326030
Index

SK Biopharmaceuticals Stock price

₩79,200.00
-8,100.00 9.28% 1M
-19,700.00 19.92% 6M
-45,400.00 36.44% YTD
-28,200.00 26.26% 1Y
-12,400.00 13.54% 3Y
-34,300.00 30.22% 5Y
-47,800.00 37.64% 10Y
-47,800.00 37.64% 20Y
Korea, Closing price Thu, Sep 17 2026
+1,000.00 1.28%
ISIN
KR7326030004
Symbol
326030
Index
Industry

Is SK Biopharmaceuticals a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,134 stocks worldwide.

Key metrics

Basic
Market capitalization
₩6.1t
Enterprise Value
₩5.8t
Net debt
positive
Cash
₩381.9b
Shares outstanding
78.3m
Valuation (TTM | estimate)
P/E
15.3
P/S
7.1 | 6.2
EV/Sales
6.7 | 5.9
EV/FCF
26.7
P/B
6.0
Financial Health
Equity Ratio
67.9%
Return on Equity
32.8%
ROCE
27.7%
ROIC
51.4%
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
₩861.3b | ₩984.8b
EBITDA
₩318.9b
EBIT
₩303.2b
Net Income
₩401.0b
Free Cash Flow
₩216.8b
Growth (TTM | estimate)
Revenue
38.9% | 39.3%
EBITDA
94.3%
EBIT
105.5%
Net Income
56.6%
Free Cash Flow
144.1%
Margin
Gross
94.0%
EBITDA
37.0%
EBIT
35.2%
Net
46.6%
Free Cash Flow
25.2%
More
EPS
₩5,119.9
FCF per Share
₩2,768.5
Short interest
-
Employees
246
Rev per Employee
₩2.9b

SK Biopharmaceuticals Stock Analysis

Unlock Scores for Free

Analyst Opinions

23 Analysts have issued a SK Biopharmaceuticals forecast:

20x Buy
87%
2x Hold
9%
1x Sell
4%

Analyst Opinions

23 Analysts have issued a SK Biopharmaceuticals forecast:

Buy
87%
Hold
9%
Sell
4%

Financial data from SK Biopharmaceuticals

Jun '26
+/-
%
861,340 861,340
39% 39%
100%
- Direct Costs 51,845 51,845
21% 21%
6%
809,495 809,495
40% 40%
94%
- Selling and Administrative Expenses 304,893 304,893
20% 20%
35%
- Research and Development Expense 185,685 185,685
16% 16%
22%
318,917 318,917
94% 94%
37%
- Depreciation and Amortization 15,701 15,701
5% 5%
2%
EBIT (Operating Income) EBIT 303,216 303,216
105% 105%
35%
Net Profit 400,956 400,956
57% 57%
47%

In millions KRW.

Don't miss a Thing! We will send you all news about SK Biopharmaceuticals directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

SK Biopharmaceuticals Co., Ltd. engages in the research and development of new drugs and antibiotics. It mainly develops new drugs for central nervous system disorders, and brain tumors. The company was founded in 1993 and is headquartered in Seongnam-si, South Korea.

Head office South Korea
CEO Mr. Lee
Employees 246
Founded 1993
Website www.skbp.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today